FDA issues rules for investigational drugs
August 17th 2009The U.S. Food and Drug Administration published two rules recently to help clarify how very ill patients can obtain access to investigational drugs and biologics when they are not eligible to participate in a clinical trial and have no other satisfactory treatment options.
NACDS, NCPA forge on with Medicaid lawsuit
August 13th 2009The National Association of Chain Drug Stores and the National Community Pharmacists Association are moving ahead with their lawsuit against Delaware's changes to Medicaid reimbursement rates, even after Walgreen Co. said it no longer supports the suit.
Rogue Internet pharmacies face new penalties
August 10th 2009The death of a teenager led Congress to pass the Ryan Haight Online Pharmacy Consumer Protection Act in 2008, amending the Controlled Substances Act to prohibit delivery, distribution, or dispensing of controlled substances over the Internet without a valid prescription.
Pharmacy medication errors may be ruled criminal
August 10th 2009Pharmacy mistakes can sometimes lead to injury or even death. Pharmacists can be held liable in a civil suit for money damages; now a pharmacist in Ohio may be convicted of a criminal charge in the accidental death of a two-year-old girl. It is possible that the effect of criminal liability upon professional practices will worsen outcomes rather than improve them.
Biologics bills duke it out in Congress
August 10th 2009In coming years, nearly half of all newly approved drugs could come from biotechnology. With stakes so high, Congress is working to create a more direct pathway for the FDA to approve "biosimilars", the generic or "follow-on" versions of biologics. Two bills before Congress approach the issues differently.
NCPA seeks to correct flex spending requirements
August 5th 2009The National Community Pharmacists Association (NCPA) recently wrote to a key standards-setting body requesting action on a number of regarding a new Internal Revenue Service requirement meant to ensure flexible spending account debit cards are used properly that is seen by the association as problematic.
California legislative committee examines pharmacy workplace issues
August 4th 2009The California State Assembly Committee on Labor and Employment recently held an informational hearing on the subject of workplace conditions in retail pharmacies. Among those testifying were pharmacists, academics, students, consumer advocates, and representatives of the California Retailers Association.
Collaboration with physicians improves patient care, revenues
August 3rd 2009Orlando, Fla.--Pharmacists can collaborate with physicians and other health professionals in many ways, including through drug therapy management programs, pharmacy vaccine programs, and practice agreements, to build revenue streams and improve patient outcomes.
NCPA continues fight against surety bond
July 29th 2009The National Community Pharmacists Association (NCPA) is still working to urge Congress to exempt community pharmacies from the Oct. 1 accreditation and surety bond requirements needed to continue providing durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) to Medicare patients.
FDA moving cautiously on tobacco regulation
July 8th 2009Congress gave the Food and Drug Administration (FDA) jurisdiction over tobacco in June, but don?t look for any quick changes in tobacco policy, products, or marketing. The agency is asking the public for guidance before jumping into regulation.
What state boards are doing about medication errors (Web Extra)
July 1st 2009As of June 2009, it appears that North Carolina remains the only state to require any consistent public reporting of pharmacy-associated medication errors. In North Carolina, pharmacists must report errors associated with deaths.
Update: NCPA accuses CVS of questionable marketing practices
May 14th 2009More than 80 community pharmacists from the National Community Pharmacists Association (NCPA) and several patients met with the Federal Trade Commission (FTC) May 13 to discuss concerns about the impact of the March 2007 CVS/Caremark merger and to urge the FTC to re-examine it.